In CRPC and NEPC, SIRT2 expression is notably upregulated through the activation of the ERK1/2 signaling pathway [91], which is often associated with chemoresistance in cancer by enhancing cellular survival mechanisms, promoting proliferation, and inhibiting apoptosis [160,161]. The gene discussed is SIRT2; the disease is cancer.